HYDERABAD: Osmania General Hospital (OGH) set an exceptional record by performing a liver transplant surgery on a Tyrosinemia patient for the first time, along with four other liver transplant ...
Giredestrant (GDC-9545, RG-6171) is under development for the treatment of solid tumors, estrogen receptor positive breast cancer ... RG6268), a CNS-active tyrosine-kinase inhibitor intended for the ...
gene mutations who have progressed after treatment with epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) Ivonescimab (AK-112) is under development for the treatment of solid ...
TNF-α has the ability to diminish insulin expression by reducing the levels of insulin receptor substrate 1 (IRS-1 ... and c-Jun N-terminal kinase (JNK) in adipocytes. This activation hampers insulin ...
Copyright: © 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
The US Food and Drug Administration (FDA) has approved datopotamab deruxtecan for the treatment of certain patients with unresectable or metastatic hormone receptor (HR)-positive, human epidermal ...
THE hemolytic anemia associated with erythrocyte pyruvate kinase deficiency is of variable severity 1–17 and probably of variable cause. In some cases severe aberrations of erythrocyte shape ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback